Floatz logo

Dapagliflozin

Gestational Diabetes

Woman'sSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Gestational Diabetes cohort.

Asset / SponsorPhaseRating
Metformin
Ain Shams University
Phase 4A
Liraglutide
Woman's
Phase 3BB
Folic Acid
University of Messina
N/AD
ADIPOQ
University of Minnesota
UnknownD
Tnf-.Alpha.
University of Minnesota
UnknownD

Same molecule, other indications

Dapagliflozin is also rated in:

type 2 diabetes mellitusActive
BBB
Indicative · Phase 4
78 / 100
View asset →
metabolic dysfunction-associated steatotic liver diseaseActive
BBB
Indicative · Phase 4
77 / 100
View asset →
arteriosclerosis disorderActive
BBB
Indicative · Phase 4
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →